Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.
Archives of General Psychiatry|February 1, 1994
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scaleR J Strassman, C R Qualls, E H Uhlenhuth, et al.
Depression and Anxiety|March 24, 2005
Potential effectiveness and safety of olanzapine in refractory panic disorderMichael Hollifield, Peter M Thompson, James E Ruiz, et al.
Psychopharmacology|January 1, 1981
Drug preference and mood in humans: preference for d-amphetamine and subject characteristicsE H Uhlenhuth, C E Johanson, K Kilgore, et al.
Psychiatry Research|April 1, 1981
Reinforcement, skin conductance, and performance in a vigilance-reaction time taskF W Hartel, E H Uhlenhuth, M W Fischman, et al.
Psychiatry Research|February 18, 2004
Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choicesVladan Starcevic, Michael Linden, E H Uhlenhuth, et al.
Current Medical Research and Opinion|January 1, 1984
A cross-national comparison of anti-anxiety/sedative drug useM B Balter, D I Manheimer, G D Mellinger, et al.
Psychopharmacology|March 23, 1977
Intensive design in evaluating anxiolytic agentsE H Uhlenhuth, D A Turner, G Purchatzke, et al.
Comprehensive Psychiatry|January 26, 2000
Predictors of comorbid personality disorders in patients with panic disorder with agoraphobiaM Latas, V Starcevic, G Trajkovic, et al.
Pageof 31